ATP-competitive, allosteric inhibitor of receptor-interacting protein kinase 1 (RIPK1) (EC50 = 182 nM) Blocks non-apoptotic cell death via inhibition of specific cellular pathway, necroptosis, which leads to necrosis (EC50 = 494nM) Reduces ischemic brain injury in mouse model of stroke